Developing a platform to improve chemical screening for drug discovery
A Machine Learning Platform for Adaptive Chemical Screening
['FUNDING_R01'] · MORGRIDGE INSTITUTE FOR RESEARCH, INC. · NIH-10894009
This study is working on a new computer system that helps scientists quickly find and test new medicines by searching through huge collections of chemical compounds, making it easier and cheaper for labs to discover better treatments for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MORGRIDGE INSTITUTE FOR RESEARCH, INC. (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-10894009 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a computational platform that enhances the process of chemical screening used in drug discovery. By utilizing advanced machine learning techniques, the platform will analyze vast virtual chemical libraries containing billions of compounds to identify promising candidates for further testing. This approach aims to make high-throughput screening more accessible and cost-effective for academic labs, ultimately improving the quality and diversity of potential drug compounds. Patients may benefit from faster and more efficient drug discovery processes that could lead to new treatments.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with conditions that currently lack effective treatments or where new drug development is urgently needed.
Not a fit: Patients with well-established treatments for their conditions may not see direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could significantly accelerate the discovery of new drugs, leading to more effective treatments for various diseases.
How similar studies have performed: Other research has shown success in using computational tools for drug discovery, indicating that this approach has the potential for significant advancements.
Where this research is happening
MADISON, UNITED STATES
- MORGRIDGE INSTITUTE FOR RESEARCH, INC. — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GITTER, ANTHONY JAMES — MORGRIDGE INSTITUTE FOR RESEARCH, INC.
- Study coordinator: GITTER, ANTHONY JAMES
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.